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Polyherbal drugs as Ayurvedic medicines are considered 
to be more effective for the management of diabetes. Diabetes 
mellitus (DM) represents a syndrome of metabolic disorders 
and complex pathophysiological interactions between hyper‑
glycemia, insulin resistance, and dysfunction of the β‑cells 
of pancreas. The available antidiabetic measures, such as oral 
hypoglycemic agents and insulin, do not effectively control the 
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ABSTRACT
In the present study, Sugar Remedy, a polyherbal formulation (manufactured by Umalaxmi Organics Pvt Ltd, Jodhpur, Rajasthan, India) 
was evaluated for its antihyperglycemic, antihyperlipidemic, and antioxidant effects against normal and streptozotocin (STZ)‑induced 
diabetic rats. Type II diabetes was induced in male Wistar rats by administration of a single intraperitoneal (IP) injection of STZ 
at a dose of 60 mg/kg. Effects of three different doses of Sugar Remedy suspension (185, 370, and 740 mg/kg/day, orally) and 
Metformin (500 mg/kg/day, orally) administered for 21 days were studied on parameters such as blood glucose, lipid profile, and 
antioxidant levels. Results were analyzed using one‑way analysis of variance (ANOVA) followed by Dunnett’s test. No significant 
changes were noticed in blood glucose, serum lipid levels, and kidney parameters in normal rats treated with Sugar Remedy suspension 
alone. The efficacy of Sugar Remedy as an antihyperglycemic, antihyperlipidemic, and antioxidant agent in STZ‑induced diabetes was 
comparable to that of the standard, 500 mg/kg of Metformin. Present findings provide experimental evidence that Sugar Remedy has 
significant antihyperglycemic, antihyperlipidemic, and antioxidative effects in diabetic experimental rats. Hence, Sugar Remedy may 
be regarded as a promising natural and safe remedy for the prevention or delay of diabetic complications.
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delayed diabetic complications like nephropathy, neuropathy, 
retinopathy, and cardiovascular diseases.[1] Oxidative tissue 
injury has been suggested to play an important role in the 
pathogenesis of diabetes and associated complications.[2] The 
antihyperglycemic effects of various plants are credited to their 
ability to restore the function of pancreatic tissues by causing 
an increase in the insulin output or by inhibiting the intestinal 
absorption of glucose or by the facilitation of metabolites in 
insulin‑dependent processes.[3] Herbal products are generally 
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considered to be least toxic and free from side effects when 
compared with their synthetic counterparts.[4]
Sugar Remedy is claimed to be a unique formulation that helps 
in holistic management of blood glucose and diabetes‑related com‑
plications. Each 100 g of Sugar Remedy contains the following as 
the major constituents: Bitter melon extract: 50 g; gudmar extract: 
16.7 g; ashwagandha extract: 8.4 g; jamun extract: 4.2 g; shilajit 
extract: 4.2 g; fenugreek extract: 4.2 g; triphala extract: 4.2 g; cin‑
namon extract: 4.2 g; and vijaysar extract: 4.2 g. The combined role 
of the key ingredients present in Sugar Remedy [Table 1] in lowering 
the blood glucose level and, thus, improving the hepatic and renal 
functions, lipid profile, and antioxidant activity is evidenced from 
previous studies performed on individual herbs, revealing their 
activities which are the following: Karela by insulin secretion, inhi‑
bition of glucose reabsorption in the gut, and increase of peripheral 
glucose utilization;[5] gudmar by regulation of β‑cell function and by 
its antioxidant activity;[6‑8] fenugreek and cinnamon by improving 
digestion, metabolism and reduction in insulin resistance and in‑
creasing hepatic glycogenesis;[9] jamun by increasing the pancreatic 
secretion of insulin;[10] shilajit by improving the neurogenic function 
associated with diabetes and through its pancreatotrophic action;[11] 
and vijaysar by pancreatic β‑cell regranulation.[12]
In the present study, attempts have been made to establish the 
scientific validity for the antihyperglycemic property of Sugar 
Remedy using streptozotocin (STZ)‑induced diabetic model in rats. 
The results of the study can serve as a step toward the development 
of an antihyperglycemic herbal therapy for diabetes.
MATERIALS AND METHODS
Animals and grouping
Male Wistar rats, 7‑8 weeks old and weighing 150‑220 g, 
were used for the present study. The rats were randomly distrib‑
uted to different groups with six animals in each. Animals were 
provided with standard pellets and drinking water ad libitum and 
were maintained at 12 h light and dark cycle. The protocol of the 
experiment (1258/ac/09/CPCSEA) was approved by the Institu‑
tional Animal Ethics Committee (IAEC), and the experiments were 
conducted in accordance with the guidelines as per the “Guide for 
the Care and Use of Laboratory Animals” and with permission 
from the “Committee for the Purpose of Control and Supervision 
of Experiments on Animals” (CPCSEA).
Drugs and chemicals
Sugar Remedy was obtained from Umalaxmi Organics Pvt 
Ltd, Jodhpur, India. The formulation was suspended in water for 
the preparation of an oral dosage formulation and administered 
by per oral (PO) route in different doses, twice daily for 21 days, 
while the control group was treated with water. STZ was obtained 
Sigma Aldrich Co, Mumbai, India. Metformin (Glyciphage, 
Franco‑Indian Pharmaceuticals Pvt Ltd) was obtained from Rina’s 
Pharma, Jodhpur, India.
Induction of diabetes
Diabetes was induced in overnight fasted rats by the intraperi‑
toneal (IP) injection of STZ dissolved in freshly prepared citrate 
Table 1. Formulated herbal drugs with antidiabetic properties




Plant family Antidiabetic and other beneficial 




Bitter melon Fruits and 
leaves
Cucurbitaceae Insulin secretion, inhibition of glucose 
reabsorption in guts, preservation of 
islet β‑cells and their functions, increase 
of peripheral glucose utilization, and 
suppression of gluconeogenic enzymes
Charantin, Momordica, 
Momordicin, Charantin, and 
Galactose‑binding lectin
Gymnema sylvestre Gudmar Leaves Asclepiadaceae Regeneration of β‑cell, reduce blood 
glucose level, increase plasma insulin 
level and hypolipidemic
Gymnemic acids 1‑4 and 
Gurmarin
Withania somnifera Ashwagandha Leaves Solanaceae Decrease blood sugar level Withanine, Somnine,
Withaferine, Withanolides
Syzygium cumini Jamun Fruit Myrtaceae Increasing either the pancreatic 
secretion of insulin or its release from 
bound insulin
Gymnemic acids, Saponins, 
Stigmasterol, Quercitol, Betaine, 
Choline
Asphaltum Shilajit ‑ ‑ Pancreatotrophic action Dibenzo‑alpha‑pyrones and 
related metabolites, small peptides
Trigonella 
foenum‑graecum
Fenugreek Seeds Fabaceae Antidiabetic and Reduces insulin 
resistance
Trigonelline, Galactomannan, 
Diosgenin Nicotinic acid, 
















Vijaysar Heart‑wood Fabaceae Hypoglycemic, improve hyperlipidema, 
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buffer (0.1 M, pH 4.5) in a volume of 1 ml/kg body weight at a 
dose of 60 mg/kg body weight.[13] Diabetes was confirmed 72 h 
after the injection by determining the blood glucose concentration. 
Only those animals with blood glucose level of >200 mg/dl (mild 
diabetes)[14,15] were used for the experiment. The diabetic animals 
were allowed free access to tap water and pelleted diet and were 
maintained at room temperature in plastic cages.
Acute toxicity studies
To study any possible toxic effects, mortality, and/or changes 
in the behavioral pattern, acute toxicity studies were performed 
according to Organisation for economic co‑operation and develop‑
ment (OECD) guidelines 423, December 2001. Experiments were 
carried out in normal rats and they were kept under closed obser‑
vation for 24 h. All symptoms including changes in awareness, 
mood, motor activity, posture activity, and mortality were recorded. 
No toxicity or mortality was observed with Sugar Remedy up to 
a dose of 1000 mg/kg body weight.[16]
Biochemical estimations
Blood glucose estimation was done using a glucometer and 
with Trinder’s enzymatic method using an autoanalyzer.[17] Lipid 
profile was checked with an autoanalyzer using the following meth‑
ods: Cholesterol oxidase‑phenol + aminophenazone (CHOD‑PAP) 
end point method was used for cholesterol estimation, phospho‑
tungstic acid end point method for high density lipoprotein (HDL) 
estimation, and glycerol‑3‑phosphate oxidase (GPO)‑Trinder end 
point method was used for triglyceride estimation.[18,19] Very low 
density lipoprotein (VLDL) and low density lipoprotein (LDL) 
fractions were calculated by using Friedewald’s equation as fol‑
lows:[20]
VLDL = triglycerides/5
LDL = TC – (HDL + VLDL)
Physiological profile of kidneys was estimated by Jaffe’s 
method Initial Rate for creatinine and modified Trinder’s method, 
end point for uric acid, using autoanalyzer.[21]
Antioxidant activity in liver tissue homogenate
By the end of the treatment period, on the next day of adminis‑
tering the last dose of the respective treatments, immediately after 
collection of blood, the animals were euthanized with an overdose 
of ether and their livers were excised, washed with ice‑cold normal 
saline, and weighed. Then, a 10% liver tissue homogenate was pre‑
pared by homogenizing in ice‑chilled phosphate‑buffered saline (PBS; 
pH 7.4) using a tissue homogenizer. The homogenate was centrifuged 
at 10,000 rpm for 4°C using a refrigerated centrifuge and the super‑
natant was used for the determination of various antioxidant param‑
eters like reduced glutathione (GSH), superoxide dismutase (SOD), 
catalase (CAT), and malondialdehyde (MDA) levels.[22‑25]
Statistical analysis
Results are expressed as mean ± standard error of mean (SEM) 
and statistical difference was evaluated using one‑way analysis of 
variance (ANOVA) followed by Dunnett’s test. Data were con‑
sidered statistically significant at a P ≤ 0.01 and highly significant 
at a P < 0.001. All the above statistical analyses were done on 
Prism software.
RESULTS
Effect of sugar remedy on blood glucose levels
STZ treatment produced significant increase in blood glu‑
cose levels (347.50 ± 21.90 mg/dl) with respect to the control 
group (109.47 ± 3.46 mg/dl). The hyperglycemia was pronounced 
after 21st day of administering STZ. As shown in Table 2, the 
administration of 740 mg/kg of Sugar Remedy or 500 mg/kg 
of Metformin significantly reversed (129.72 ± 8.25 mg/dl and 
128.2 ± 12.46 mg/dl, respectively) the increase in blood glucose 
concentration induced by STZ. Such an effect was more obvious 
with high dose of Sugar Remedy (740 mg/kg body weight).
Effect of sugar remedy on the lipid profile
STZ produced significant increases in serum triglycer‑
ides (153.63 ± 3.77 vs. 78.61 ± 7.35 mg/dl in normal control rats), 
serum cholesterol (123.17 ± 0.78 vs. 76.35 ± 3.06 mg/dl in normal 
control rats), LDL (80.96 ± 1.02 vs. 30.04 ± 1.90 mg/dl in normal 
control rats), and VLDL (30.73 ± 0.72 vs. 16.67 ± 1.37 mg/dl in 
normal control rats), as well as marked reduction in serum HDL 
levels (11.48 ± 0.67 vs. 29.60 ± 1.10 mg/dl in normal control 
rats). As shown in Table 3, treatment with 740 mg/kg of Sugar 
Remedy reduced the levels of serum cholesterol, triglycerides, 
VLDL, and LDL (81.20 ± 1.64, 102.35 ± 1.55, 20.47 ± 0.31, and 
36.95 ± 1.37 mg/dl, respectively), which was comparable to the 
levels in control group (76.35 ± 3.06, 78.61 ± 7.35, 16.67 ± 1.37, 
and 30.04 ± 1.90 mg/dl, respectively). Metformin at a dose of 500 
mg/kg also produced the same effect (80.16 ± 1.01, 99.63 ± 3.01, 
19.92 ± 0.60, and 33.97 ± 0.85 mg/dl, respectively). Increase in 
HDL levels was also much pronounced in animals treated with 740 
mg/kg of Sugar Remedy or 500 mg/kg of Metformin (23.78 ± 1.00 
and 26.26 ± 0.56 mg/dl, respectively) which was comparable to 
the normal control animals (29.60 ± 1.10 mg/dl).
Table 2. Effect of Sugar remedy on serum glucose levels
Groups 0 day 7th day 14th day 21st day
Normal control 109.47±3.46 109.93±3.86 109.66±3.36 108.21±3.00
Diabetic control 347.50±21.90 342.76±21.48 345.78±23.03 350.26±26.95
Std. metformin (500 mg/kg) 318.83±20.24ns 214.03±19.32c 166.56±12.82c 128.20±12.46c
Sugar remedy (185 mg/kg) 307.16±10.84b 258.85±11.35c 193.48±8.14c 146.52±2.93c
Sugar remedy (370 mg/kg) 334.66±23.87b 245.68±32.18c 188.68±20.40c 135.22±4.94c
Sugar remedy (740 mg/kg) 327.33±16.97b 225.65±10.44c 170.35±7.31c 129.72±8.25c
All values in tables are expressed as mean±S.E.M; a;b;cdenotes statistically significantly mean, ns non significant, aP<0.05, bP<0.01, cP<0.0001
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Effect of sugar remedy on kidney and liver parameters
STZ‑diabetic (DC) rats exhibited higher serum creati‑
nine (2.55 ± 0.18 mg/dl) and uric acid (9.26 ± 0.18 mg/dl) levels 
as compared to those of normal control rats (0.86 ± 0.05 and 
3.26 ± 0.09 mg/dl, respectively) [Table 4]. Chronic treatment with 
740 mg/kg of Sugar Remedy significantly reduced the elevated cre‑
atinine as well as uric acid levels in diabetic rats (1.01 ± 0.24 mg/dl 
and 4.33 ± 0.39 mg/dl, respectively), which was comparable to 
the levels in Metformin (500 mg/kg) treated animals (1.69 ± 0.21 
and 6.09 ± 1.17 mg/dl, respectively).
Aspartate transaminase (AST) level was significantly reduced in 
rats treated with 740 mg/kg of Sugar Remedy (83.69 ± 1.45 U/l) or 
500 mg/kg of Metformin (86.35 ± 10.40 U/l) when compared to dia‑
betic control rats (102.00 ± 8.38 U/l). Similarly, alanine transaminase 
(ALT) level was significantly reduced in rats treated with 740 mg/kg 
of Sugar Remedy or 500 mg/kg of Metformin (33.02 ± 3.80 U/l and 
45.15 ± 1.33 U/l, respectively), when compared to diabetic control rats 
(88.60 ± 5.62 U/l). This indicates that Sugar Remedy also improved 
the liver physiology and may have hepatoprotective effects [Table 4].
Effect of sugar remedy on the antioxidant parameters in liver
DC rats showed a significant decrease in SOD, CAT, and 
GSH levels (6.06 ± 0.10, 0.59 ± 0.01 units/min/mg protein and 
1.80 ± 0.10 units/mg protein, respectively) when compared with 
the normal control animals (17.89 ± 1.42, 1.30 ± 0.63 units/min/
mg protein and 4.58 ± 1.42 mg/g protein, respectively). Thiobar‑
bituric acid reactive substances (TBARS) significantly increased 
following STZ administration (46.41 ± 0.51 nmol/mg protein) in 
DC rats when compared to normal control rats (24.10 ± 0.51 nmol/
mg protein). Administration of Sugar Remedy in various doses 
for 21 days produced a marked increase in the antioxidant (SOD, 
GSH, and CAT) levels, whereas it produced a significant decrease 
in the prooxidant parameter (TBARS) [Table 5].
DISCUSSION
DM is one of the most common chronic diseases, and is associ‑
ated with hyperlipidemia and co‑morbidities such as obesity and 
hypertension. Hyperlipidemia is a metabolic complication of both 
Table 3. Effect of Sugar remedy on lipid profile
Groups Lipid profile parameters
Cholesterol Triglyceride HDL VLDL LDL
Normal control 76.35±3.06 78.61±7.35 29.60±1.10 16.67±1.37 30.04±1.90
Diabetic control 123.17±0.78 153.63±3.77 11.48±0.67 30.73±0.72 80.96±1.02
Std. metformin (500 mg/kg) 80.16±1.0c 99.63±3.01c 26.26±0.56c 19.92±0.60c 33.97±0.85c
Sugar remedy (185 mg/kg) 101.20±1.47b 125.05±2.27ns 12.97±0.88ns 25.01±0.45ns 63.22±1.20b
Sugar remedy (370 mg/kg) 89.33±1.34c 113.96±3.32b 20.21±0.70b 22.79±0.66c 46.32±1.04b
Sugar remedy (740 mg/kg) 81.20±1.64c 102.35±1.55c 23.78±1.00c 20.47±0.31c 36.95±1.37c
All values in tables are expressed as mean±S.E.M; a;b;cdenotes statistically significantly mean, ns non significant, aP<0.05, bP<0.01, cP<0.0001. HDL: High 
density lipoprotein; VLDL:Very low; density lipoprotein; LDL:Low density lipoprotein
Table 4. Effect of sugar remedy on serum creatinine and uric acid levels
Groups Liver and kidney parameters
AST ALT Creatinine Uric acid
Normal control 56.90±3.01 30.37±1.63 0.86±0.05 3.26±0.09
Diabetic control 102.00±8.38 88.6±5.62 2.55±0.18 9.26±0.18
Std. metformin (500 mg/kg) 86.35±10.40c 45.15±1.33c 1.69±0.21c 6.09±1.17c
Sugar remedy (185 mg/kg) 95.58±3.25ns 67.7±3.30b 1.99±0.98b 8.54±0.47ns
Sugar remedy (370 mg/kg) 85.48±3.26b 39.24±2.76c 1.21±0.06c 5.43±0.94c
Sugar remedy (740 mg/kg) 83.69±1.45c 33.02±3.80c 1.01±0.24c 4.33±0.39c
All values in tables are expressed as mean±S.E.M; a;b;cdenotes statistically significantly mean, ns non significant, aP<0.05, bP<0.01, cP<0.0001. 
AST:Aspartate transaminase; ALT: Alanine transaminase










Normal control 17.89±1.42 4.58±1.42 1.30±0.63 24.10±0.51
Diabetic control 6.06±0.10 1.80±0.10 0.59±0.01 46.41±0.51
Std. metformin (500 mg/kg) 15.86±0.16b 3.39±3.44b 1.19±0.26b 29.23±1.09c
Sugar remedy (185 mg/kg) 8.38±0.24ns 2.39±0.99ns 0.70±0.04ns 39.62±0.27c
Sugar remedy (370 mg/kg) 13.74±0.18a 3.20±1.16a 0.91±0.15a 34.46±0.29c
Sugar remedy (740 mg/kg) 14.96±0.17a 3.41±1.56b 0.94±0.16a 29.08±0.45c
All values in tables are expressed as mean±S.E.M; a;b;cdenotes statistically significantly mean, ns non significant, aP<0.05, bP<0.01, cP<0.0001. SOD: 
Superoxide dismutase; GSH: Glutathione; TBARS: Thiobarbituric; acid reactive substances
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clinical and experimental diabetes.[26] STZ, a β‑cytotoxin, induces 
“chemical diabetes” in a wide variety of animal species, including 
rats, by selectively damaging the insulin‑secreting β‑cells of the 
pancreas. IP injection of STZ produces fragmentation of DNA of 
the β‑cells of pancreas, which stimulates poly (ADP‑ribose) and 
depletes nicotinamide adenine dinucleotide (NAD) ultimately 
leading to the destruction of β‑cells. It is evidenced by the clini‑
cal symptoms of hyperglycemia and hypoinsulinemia. The serum 
glucose, lipid, and cholesterol values for the rats are in agreement 
with those expected for STZ‑diabetic rats.[27‑30]
Decrease in blood glucose levels was found to be more ef‑
fective with Sugar Remedy in doses of 370 and 740 mg/kg. 
Metformin showed rapid normalization of blood glucose due to 
its insulin releasing effects. Treatment with polyherbal formula‑
tion Sugar Remedy caused significant decrease in fasting serum 
glucose (FBG) level near to that of healthy control rats. The plant 
extracts may involve one or more compounds which decrease the 
blood glucose levels, suggesting that the natural constituents could 
act synergistically to induce a hypoglycemic effect as described by 
Marles et al.[31‑33] These effects might be achieved by facilitating in‑
sulin release from pancreatic β‑cells, inhibiting glucose absorption 
in the gut, stimulating glycogenesis in the liver, and/or increasing 
glucose utilization by the body. These compounds also exhibited 
antioxidant and hypolipidemic activities, restored the enzymatic 
functions, and helped in repair and regeneration of pancreatic islets 
and the alleviation of liver and renal damage.[31,34‑42]
Insulin deficiency may be responsible for dyslipidemia because 
insulin has an inhibitory action on 3‑hydroxy‑3‑methyl‑gluta‑
ryl‑CoA (HMG‑CoA) reductase, a key enzyme that is rate limit‑
ing in the metabolism of cholesterol‑rich LDL particles.[43] The 
development of hypertriglyceridemia in uncontrolled diabetes in 
humans (possibly in insulin‑deficient STZ‑diabetic rats) may be 
due to a number of metabolic abnormalities that occur sequentially. 
Acute insulin deficiency initially causes an increase in free fatty 
acid mobilization from the adipose tissue, resulting in increased 
secretion of VLDL and triglycerides from the liver.[44] In diabetic 
rats, there is a decrease in lipoprotein lipase activity,[45] resulting in 
impaired clearance of VLDL and chylomicrons from the plasma.[46]
Administration of Sugar Remedy decreased the levels of tissue 
free fatty acids and phospholipids. Accumulation of triglycerides 
is one of the risk factors in coronary heart disease (CHD). The 
significant increase in the level of triglycerides in the liver and 
kidney of diabetic control rats may be due to the lack of insulin. 
Under normal conditions, insulin activates the enzyme lipopro‑
tein lipase and hydrolyzes triglycerides. Sugar Remedy reduces 
triglycerides in the tissues of STZ‑induced diabetic rats and may 
prevent the progression of CHD.[47]
The decreased activities of CAT and SOD in the diabetic group 
may be a response to the increased production of H2O2 and O2 by 
the auto‑oxidation of glucose and nonenzymatic glycation. Hepatic 
SOD and CAT activities were reduced during diabetes and this 
may result in a number of harmful effects due to the accumulation 
of hydrogen peroxides and superoxide radicals. Administration 
of Sugar Remedy caused decreased lipid peroxidation, which 
is associated with increased SOD and CAT activities, indicating 
that Sugar Remedy can reduce reactive oxygen free radicals and 
improve the activities of the hepatic antioxidant enzymes. The 
antioxidative activity of Sugar Remedy gains further evidence 
from the quantification of TBARS in hepatic tissues, as an inverse 
relationship was found between the activities of antioxidant 
enzymes and the quantity of free radicals, which is in agreement 
with previous reports.[48,49] In diabetes, AST and ALT activities are 
increased,[50] which may be due to the cellular damage.[51] The plant 
extract was observed to normalize the levels of these enzymes, 
which indicates that it has a promising antidiabetic effect without 
inducing toxicity.
Administration of Sugar Remedy and Metformin reduced 
the lipid peroxidative markers in the liver and kidney tissues of 
diabetic rats. This indicates that Sugar Remedy inhibits oxidative 
damage due to the antiperoxidative effect of its ingredients. This 
could be correlated with previous studies reporting that Momordica 
charantia,[52] Gymnema sylvestre,[53] Withania somnifera,[54] Syzy‑
gium cumini,[55] Asphaltum,[11] Trigonella foenum‑graecum,[56] 
Triphala,[57] Cinnamomum zeylanicum,[58] and Pterocarpus mar‑
supium[59] (ingredients of Sugar Remedy) have antiperoxidative 
and antihyperlipidemic effects in diabetic animals.
The antidiabetic and antihyperlipidemic effects of Sugar 
Remedy may be due to the effect of active constituents of dif‑
ferent plants, viz., momorcharin and momordicin isolated from 
M. charantia; gymnemic acids 1‑4 and gurmarin from G. syl‑
vestre; withanine, somnine, withaferine, and withanolides from 
W. somnifera; gymnemic acids, saponins, stigmasterol, quercitol, 
betaine, and choline from S. cumini; dibenzo‑alpha‑pyrones and 
related metabolites, and small peptides from Asphaltum; trigonel‑
line and scopoletin from T. foenum‑graecum; epicatechin from 
P. emblica; volatile oil, tannin, mannitol, and calcium oxalate 
from C. zeylanicum; and (−)‑epicatechin, aurones, pterostilbene, 
marsupol, and isoliquiritigenin from P. marsupium, which may 
be responsible for scavenging the free radicals liberated by STZ 
in diabetic rats.[9‑11,60‑62]
CONCLUSION
On the basis of the aforementioned results, it may be concluded 
that Sugar Remedy has significant antihyperglycemic, antihyper‑
lipidemic, and antioxidative effects in diabetic experimental rats. 
Hence, Sugar Remedy may be regarded as a promising natural and 
safe remedy for the prevention or delay of diabetic complications.
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